A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease. OH&RM [Internet]. 29 sept. 2023 [cité 24 août 2026];4(4):19-26. Disponible sur: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/374